Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ACACB | O00763 | 8/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.42 |
| ▸ | ACACA | Q13085 | 6/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | GRN | P28799 | 1/20 | 0.40 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20482157 | 0.86 | ALDH1A1 (0.51) | ALDH1A1HPGDSMN1; SMN2ACACBHRH3 | |
| SCHEMBL21656515 | 0.86 | MAPT (0.56) | ACACBHRH3ACACAHDAC8HDAC6 | |
| SCHEMBL21656612 | 0.85 | OPRM1 (0.56) | OPRM1OPRD1OPRK1 | |
| SCHEMBL21628814 | 0.84 | HPGD (0.69) | ALDH1A1HPGDSMN1; SMN2HDAC8HDAC6 | |
| SCHEMBL21656683 | 0.84 | LMNA (0.55) | ACACBACACAHDAC8HDAC6OPRM1 | |
| SCHEMBL21628611 | 0.83 | ALDH1A1 (0.51) | ALDH1A1HPGDSMN1; SMN2HRH3OPRM1 | |
| SCHEMBL21657001 | 0.82 | OPRM1 (0.55) | HPGDSMN1; SMN2ACACBHRH3ACACA | |
| SCHEMBL21656691 | 0.82 | PDE4B (0.53) | ALDH1A1ACACBACACAHDAC8HDAC6 | |
| SCHEMBL21628402 | 0.82 | HDAC6 (0.61) | ACACBACACAHDAC8HDAC6OPRM1 | |
| SCHEMBL21628603 | 0.81 | SMN1; SMN2 (0.56) | ALDH1A1HPGDSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | ALDH1A1 717/4885HPGD 2579/4885SMN1; SMN2 796/4885 |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | ALDH1A1 717/4885HPGD 2579/4885SMN1; SMN2 796/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | ALDH1A1 900/4885HPGD 2313/4885SMN1; SMN2 1107/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | ALDH1A1 717/4885HPGD 2579/4885SMN1; SMN2 796/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | ALDH1A1 929/4885HPGD 3694/4885SMN1; SMN2 919/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | ALDH1A1 717/4885HPGD 2579/4885SMN1; SMN2 796/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | ALDH1A1 717/4885HPGD 2579/4885SMN1; SMN2 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.